Who We Are

The Medicines Patent Pool (MPP) is a United Nations-backed public health organisation working to increase access to HIV, hepatitis C and tuberculosis treatments in low- and middle-income countries.

MedsPaL

The Medicines Patents & Licences Database
MedsPaL provides information on the patent and licensing status of selected HIV, hepatitis C and tuberculosis medicines in low- and middle-income countries.

Transparency in the MPP

All MPP licences are publicly available in their entirety on the MPP website. This is unprecedented in the pharmaceutical field.

MPP in Numbers

Hover over the numbers to find out more
9
9 patent holders with MPP signed agreements
12.9
12.9 million patient-years through MPP’s generic partners
20
20 generic manufacturers and product developers sublicensed from the MPP
16
16 products licensed to the MPP
120+
120+ ongoing pharmaceutical development projects
87% to 91%
87% to 91% of people living with HIV in developing countries covered by the MPP adult licences
92 to 131
92 to 131 countries covered by MPP adults licences
312
312 million dollars saved, from 2012 to December 2016

Latest News

Videos

See More

Endorsements

See More
“The availability of generic atazanavir will bring more treatment options for PLHIV in Indonesia. Considering that atazanavir has lower pill counts and more favourable effects on lipid levels than existing protease inhibitors used in-...”

This website uses cookies to ensure you get the best experience on our website. Learn More